kongre.net
Welcome to kongre.net

Speaker

Jeffrey Bornstein

CMO, Mediar Therapeutics

Jeffrey Bornstein, CMO at Mediar Therapeutics, is speaking at 10th Antifibrotic Drug Development Summit 2026 (Boston, United States of America, 1–3 Dec 2026) in the session “Workshop C: Building Predictive Biomarker & Endpoint Strategies to Prove Antifibrotic Activity Earlier in Clinical Development”.

Conferences
1
Keynotes
0
Upcoming
1

Upcoming appearances

More speakers at 10th Antifibrotic Drug Development Summit 2026

  • Rebecca Taub

    Director, Madrigal Pharmaceuticals

  • Bernard Allan

    Executive Director & Head of Liver Disease Research & Drug Discovery, GI-Ddu, Takeda Pharmaceutical

  • Alexander Barron

    Principal Scientist II, Novartis AG

  • Victor Bustos

    Co-Founder & Chief Executive Officer, Refoxy Pharmaceuticals

  • Steve De Vos

    Head of Translational Sciences, Fibrocor Therapeutics

  • Zoltan Derdak

    Medical Director, Takeda Pharmaceutical

See all 21 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jeffrey Bornstein, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].